is semaglutide patented ICYMI: Shortly after Novo Nordisk's patent expired, several domestic pharmaceutical giants began launching their own generic versions of Ozempic, slashing prices by up to 90 per cent. The sharp price reduction Generic injectable semaglutide could cost

Where Ozempic (semaglutide) is a pure GLP-1 receptor agonist, Retatrutide is a triple agonist working on: GLP-1 improves insulin sensitivity, reduces appetite, slows stomach emptying GIP (Glucose-dependent insulinotropic peptide) enhances insulin secretion, may preserve beta cells, and appears to help prevent the dreaded weight plateau seen with GLP-1 alone Glucagon receptor promotes fat metabolism and increases energy expenditure This means that not only does Retatrutide regulate blood sugar and suppress appetite like Ozempic it also burns more fat and preserves more muscle while you lose weight

Secondary outcomes examined worsening of depression or anxiety separately, substance use disorders, and self-harm incidents

Rather, steady all day energy

Loss of firmness / Elasticity

Status epilepticus in adults